1. Home
  2. AXGN vs COLL Comparison

AXGN vs COLL Comparison

Compare AXGN & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Axogen Inc.

AXGN

Axogen Inc.

HOLD

Current Price

$34.76

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$45.85

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AXGN
COLL
Founded
N/A
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
AXGN
COLL
Price
$34.76
$45.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
6
Target Price
$33.67
$51.17
AVG Volume (30 Days)
891.3K
493.0K
Earning Date
02-24-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.63
Revenue
$214,709,000.00
$757,067,000.00
Revenue This Year
$21.87
$26.17
Revenue Next Year
$15.69
$3.65
P/E Ratio
N/A
$27.99
Revenue Growth
18.72
26.34
52 Week Low
$9.22
$23.23
52 Week High
$34.71
$50.79

Technical Indicators

Market Signals
Indicator
AXGN
COLL
Relative Strength Index (RSI) 64.42 45.69
Support Level $31.50 $44.43
Resistance Level $33.57 $48.29
Average True Range (ATR) 1.60 2.05
MACD 0.01 -0.22
Stochastic Oscillator 95.44 28.48

Price Performance

Historical Comparison
AXGN
COLL

About AXGN Axogen Inc.

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

Share on Social Networks: